ghk cu and cancer What Is GHK-Cu Peptide? FDA scientists flag concerns with

In the preclinical literature it is studied primarily as a cytoprotective and angiogenic agent, meaning research examines how it may influence the survival of cells under stress and the formation of new blood vessels in laboratory models

I mentioned in my first discussion of orforglipron (Link here: ADA Conference 2025: Orforglipron & Bimagrumab) that it requires no special dosing as it is a traditional small molecule drug

IV Therapy IV therapy delivers beneficial nutrients directly to the cells that need them, ensuring 100% absorption for maximum benefit

Unlike oral supplements, injections bypass the digestive system, ensuring optimal absorption for those with deficiencies or difficulty absorbing B12 from food